Opioid Use Disorder and Role of Yoga As an Adjunct in Management (OUDARYAM): Study Protocol for a Randomized Controlled Trial

Overview

Journal Wellcome Open Res

Specialty Biomedical Engineering

Date 2024 Jul 17

PMID 39015614

Authors

Hemant Bhargav

Bharath Holla

Jayant Mahadevan

Nishitha Jasti

Mariamma Philip

Priyamvada Sharma

Vedamurthachar A

Urvakhsh Meherwan Mehta

Shivarama Varambally

Ganesan Venkatasubramanian

Prabhat Chand

Gangadhar Bn

Kevin P Hill

Nicolas R Bolo

Matcheri Keshavan

Pratima Murthy

Affiliations

Soon will be listed here.

Abstract

Background: The proposed research aims to test the effects and mechanisms of a six-month yoga-based intervention as an add-on to standard treatment in opioid use disorder (OUD) by conducting a randomized controlled study with the following primary outcome variables: 1) clinical: abstinence (opioid negative urine test), and reductions in pain and craving, and 2) mechanisms: reward circuit activation in response to opioid visual cue craving paradigm, activation in response to a cognitive control task, and resting state functional connectivity through fMRI, and plasma beta-endorphin levels. Secondary outcome variables are perceived stress, anxiety, sleep quality, cognitive performance, pain threshold, buprenorphine dosage and side effects, withdrawal symptoms, socio-occupational functioning, vedic personality traits, heart rate variability, serum cortisol, and brain GABA levels through magnetic resonance spectroscopy (MRS).

Methods: In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 164 patients with OUD availing the outpatient/ inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups - yoga arm (standard treatment + yoga-based intervention), or waitlist group (standard treatment alone). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized yoga program for OUD will be used as an intervention. Participants in the yoga arm will receive 10 supervised in-person sessions of yoga in the initial two weeks followed by tele-yoga sessions thrice a week for the next 22 weeks. The wait-list control group will continue the standard treatment alone for 24 weeks. Assessments will be done at baseline, two weeks, 12 weeks, and 24 weeks. Data from all randomized subjects will be analysed using intent-to-treat analysis and mixed model multivariate analysis.

Dissemination: Findings will be disseminated through peer-reviewed publication, conference presentations, and social media.

Trial Registration Number: The trial has been registered under Clinical Trials Registry-India with registration number CTRI/2023/03/050737.

References

Varshney P, Bhargav H, Vidyasagar P, Venugopal S, Arsappa R, Narasimha V . Yoga as an Adjunct for Management of Opioid Dependence Syndrome: A Nine-Month Follow-Up Case Report. Case Rep Psychiatry. 2021; 2021:5541995. PMC: 8324390. DOI: 10.1155/2021/5541995. View

Brooks J, Lawlor S, Turetzkin S, Goodnight C, Galantino M . Yoga for Substance Use Disorder in Women: A Systematic Review. Int J Yoga Therap. 2020; 31(1). DOI: 10.17761/2021-D-20-00008. View

Avasthi A, Basu D, Subodh B, Gupta P, Goyal B, Sidhu B . Epidemiology of dependence on illicit substances, with a special focus on opioid dependence, in the State of Punjab, India: Results from two different yet complementary survey methods. Asian J Psychiatr. 2018; 39:70-79. DOI: 10.1016/j.ajp.2018.12.008. View

Uebelacker L, Van Noppen D, Tremont G, Bailey G, Abrantes A, Stein M . A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder. J Subst Abuse Treat. 2019; 105:19-27. PMC: 6709876. DOI: 10.1016/j.jsat.2019.07.015. View

Tyagi A, Cohen M . Yoga and heart rate variability: A comprehensive review of the literature. Int J Yoga. 2016; 9(2):97-113. PMC: 4959333. DOI: 10.4103/0973-6131.183712. View

Baykara S, Alban K . The effects of buprenorphine/naloxone maintenance treatment on sexual dysfunction, sleep and weight in opioid use disorder patients. Psychiatry Res. 2019; 272:450-453. DOI: 10.1016/j.psychres.2018.12.153. View

Larance B, Ambekar A, Azim T, Murthy P, Panda S, Degenhardt L . The availability, diversion and injection of pharmaceutical opioids in South Asia. Drug Alcohol Rev. 2011; 30(3):246-54. DOI: 10.1111/j.1465-3362.2011.00304.x. View

Shaffer H, LaSalvia T, Stein J . Comparing Hatha yoga with dynamic group psychotherapy for enhancing methadone maintenance treatment: a randomized clinical trial. Altern Ther Health Med. 1997; 3(4):57-66. View

Tolahunase M, Sagar R, Faiq M, Dada R . Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial. Restor Neurol Neurosci. 2018; 36(3):423-442. DOI: 10.3233/RNN-170810. View

10.

Messina B, Worley M . Effects of craving on opioid use are attenuated after pain coping counseling in adults with chronic pain and prescription opioid addiction. J Consult Clin Psychol. 2019; 87(10):918-926. PMC: 7039171. DOI: 10.1037/ccp0000399. View

11.

Bandawar M, Kandasamy A, Chand P, Murthy P, Benegal V . Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study. Indian J Psychol Med. 2015; 37(3):330-2. PMC: 4649800. DOI: 10.4103/0253-7176.162951. View

12.

Lander L, Chiasson-Downs K, Andrew M, Rader G, Dohar S, Waibogha K . Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone. J Addict Res Ther. 2019; 9(1):354. PMC: 6390289. DOI: 10.4172/2155-6105.1000354. View

13.

Holla B, Taylor P, Glen D, Lee J, Vaidya N, Mehta U . A series of five population-specific Indian brain templates and atlases spanning ages 6-60 years. Hum Brain Mapp. 2020; 41(18):5164-5175. PMC: 7670651. DOI: 10.1002/hbm.25182. View

14.

Mallik D, Bowen S, Yang Y, Perkins R, Sandoz E . Raja yoga meditation and medication-assisted treatment for relapse prevention: A pilot study. J Subst Abuse Treat. 2018; 96:58-64. DOI: 10.1016/j.jsat.2018.10.012. View

15.

Tsai A, Kiang M, Barnett M, Beletsky L, Keyes K, McGinty E . Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019; 16(11):e1002969. PMC: 6957118. DOI: 10.1371/journal.pmed.1002969. View

16.

Lange W, Fudala P, Dax E, Johnson R . Safety and side-effects of buprenorphine in the clinical management of heroin addiction. Drug Alcohol Depend. 1990; 26(1):19-28. DOI: 10.1016/0376-8716(90)90078-s. View

17.

Khanna S, Greeson J . A narrative review of yoga and mindfulness as complementary therapies for addiction. Complement Ther Med. 2013; 21(3):244-52. PMC: 3646290. DOI: 10.1016/j.ctim.2013.01.008. View

18.

McHugh R, Fitzmaurice G, Carroll K, Griffin M, Hill K, Wasan A . Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug Alcohol Depend. 2014; 145:121-6. PMC: 4254575. DOI: 10.1016/j.drugalcdep.2014.10.002. View

19.

Dhawan A, Chopra A, Jain R, Yadav D, Vedamurthachar . Effectiveness of yogic breathing intervention on quality of life of opioid dependent users. Int J Yoga. 2015; 8(2):144-7. PMC: 4479894. DOI: 10.4103/0973-6131.154075. View

20.

Baker A, Garland E . Autonomic and affective mediators of the relationship between mindfulness and opioid craving among chronic pain patients. Exp Clin Psychopharmacol. 2018; 27(1):55-63. PMC: 6355352. DOI: 10.1037/pha0000225. View